The last three decades have been characterized by an exponential increase in knowledge
and advances in the clinical management of atrial fibrillation. The purpose of the study is to …

Atrial fibrillation (AF) is highly prevalent with a lifetime risk of about 1 in 3–5 individuals after
the age of 45 years. Between 2010 and 2019, the global prevalence of AF has risen …

A healthy brain is protected by the blood–brain barrier (BBB), which is formed by the
endothelial cells that line brain capillaries. The BBB plays an extremely important role in …

Summary Globally, up to 1· 5 million individuals with ischaemic stroke or transient ischaemic
attack can be newly diagnosed with atrial fibrillation per year. In the past decade, evidence …

Introduction: Prolonged cardiac monitoring (PCM) substantially improves the detection of
subclinical atrial fibrillation (AF) among patients with history of ischemic stroke (IS), leading …

Hypertension is prevalent in> 70% of atrial fibrillation patients. In turn, hypertensive patients
have up to 73% greater likelihood of atrial fibrillation. Current guidelines recommend that a …

Atrial fibrillation (AF) is the most prevalent arrhythmia worldwide. The presence of AF is
associated with increased risk of systemic thromboembolism, but with the uptake of oral …

Background The outcome implications of asymptomatic vs. symptomatic atrial fibrillation (AF)
in specific groups of patients according to clinical heart failure (HF) and left ventricular …

Importance Atrial fibrillation (AF) screening trials have failed to demonstrate a significant
reduction in stroke risk. The impact on stroke severity and the importance of prior strokes are …

Aims There are few data on the feasibility of population screening for paroxysmal atrial
fibrillation (AF) using hand-held electrocardiogram (ECG) devices outside a specialist …